It has been postulated that the activation of the miR-373-TXNIP-HIF1α-TWIST signaling axis is related to the poor prognosis of breast cancer patients (Figure 2A) and that TXNIP levels may be a potential prognostic biomarker for breast cancer (14). Here, HIF1A is linked to breast carcinoma.